LNWWM
HZNP

Laird Norton Wetherby Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,238
Closed -$375K – 985
2023
Q3 		$375K Sell
3,238
-249
-7% -$26.8K 0.02% 612
2023
Q2 		$359K Sell
3,487
-32
-0.9% -$3.38K 0.02% 653
2023
Q1 		$384K Sell
3,519
-58
-2% -$6.41K 0.02% 624
2022
Q4 		$407K Buy
3,577
+45
+1% +$3.74K 0.03% 585
2022
Q3 		$219K Buy
+3,532
New +$247K 0.02% 781
2022
Q2 		– Sell
-2,328
Closed -$245K – 1000
2022
Q1 		$245K Sell
2,328
-127
-5% -$12.4K 0.01% 786
2021
Q4 		$265K Buy
2,455
+45
+2% +$4.91K 0.01% 769
2021
Q3 		$264K Buy
2,410
+161
+7% +$16.7K 0.02% 766
2021
Q2 		$211K Buy
+2,249
New +$207K 0.01% 853

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's HZNP Position: Q4 2023 in Review

Laird Norton Wetherby Wealth Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 3,238 shares — an estimated $375K sold.

Laird Norton Wetherby Wealth Management first reported a position in HZNP in Q2 2021 and held it in 9 quarters. The position peaked at $407K in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Laird Norton Wetherby Wealth Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Laird Norton Wetherby Wealth Management sold 3,238 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $375K.
  • Laird Norton Wetherby Wealth Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2021 and held it in 9 quarters.
  • Laird Norton Wetherby Wealth Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $407K in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q4 2023, filed 14 Feb 2024.